SCHEMBL23172313

SCHEMBL23172313

Nc1ccc(ON2CCN(c3ccc4c(c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)nc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 17/20 0.63
▸ DDB1 Q16531 10/20 0.58
▸ HPGDS O60760 2/20 0.49
▸ IKZF3 Q9UKT9 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ CHRM2 P08172 1/20 0.46
▸ OPRM1 P35372 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ TNF P01375 1/20 0.45
▸ IL1B P01584 1/20 0.45
▸ TBXA2R P21731 1/20 0.45
▸ IKZF1 Q13422 1/20 0.45
▸ EGFR P00533 2/20 0.43
▸ AR P10275 1/20 0.43
▸ BTK Q06187 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23133938 0.86 CRBN (0.69) CRBNDDB1HPGDSIKZF3ALDH1A1
SCHEMBL23133944 0.84 CRBN (0.56) CRBNDDB1HPGDSEGFR
SCHEMBL25172415 0.84 CRBN (0.80) CRBNDDB1HPGDSIKZF3ALDH1A1
SCHEMBL30400867 0.84 CRBN (0.80) CRBNDDB1HPGDSIKZF3ALDH1A1
SCHEMBL23117898 0.79 CRBN (0.58) CRBNDDB1HPGDSEGFRAR
SCHEMBL30139774 0.79 CRBN (0.95) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL21946744 0.79 CRBN (0.95) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL30139721 0.79 CRBN (0.95) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL25170816 0.79 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL30798398 0.79 CRBN (0.95) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021061642-A1 NOVEL UREAS HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF ACCUTAR BIOTECHNOLOGY INC. (US) 2021-04-01 — — WO disclosed
Send feedback